Assessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
On the Frontlines of PsoriasisAssessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
Mary Leuchars, MD
Jeffrey Cohen, MD, MPH
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Living RheumThe Potential Role of GLP-1s in Psoriatic Arthritis Management
Philip Mease, MD, MACR
SGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Living RheumSGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart MattersSubcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
Updated AACE Guidance on Managing Dyslipidemia in T2D
Heart MattersUpdated AACE Guidance on Managing Dyslipidemia in T2D
Scott D. Isaacs, MD FACP, FACE
Exploring the Risk of Type 2 Diabetes Following SARS-CoV-2 Infection
Clinician's RoundtableExploring the Risk of Type 2 Diabetes Following SARS-CoV-2 Infection
Carolyn Bramante
- advertisement
Beyond the Flu: Safeguarding Older Adults Through Vaccination
VacciNationBeyond the Flu: Safeguarding Older Adults Through Vaccination
Jennifer Caudle, DO, FACOFP
Stephen Thomas, MD
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
How GLP-1s Provide New Options to Manage Heart Disease
Medical Industry FeatureHow GLP-1s Provide New Options to Manage Heart Disease
David Majure, M.D., MPH
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Charles Turck, PharmD, BCPS, BCCCP
Jamy Ard, MD
Michelle I. Cardel, PhD, MS, RD
- advertisement